WO2003088889A1 - Self administered lymphatic massage - Google Patents

Self administered lymphatic massage Download PDF

Info

Publication number
WO2003088889A1
WO2003088889A1 PCT/AU2003/000467 AU0300467W WO03088889A1 WO 2003088889 A1 WO2003088889 A1 WO 2003088889A1 AU 0300467 W AU0300467 W AU 0300467W WO 03088889 A1 WO03088889 A1 WO 03088889A1
Authority
WO
WIPO (PCT)
Prior art keywords
massage
pad
lymphatic
self administered
vibratory
Prior art date
Application number
PCT/AU2003/000467
Other languages
French (fr)
Inventor
Neil Piller
Original Assignee
Cypro-Ssage Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cypro-Ssage Pty Ltd filed Critical Cypro-Ssage Pty Ltd
Priority to AU2003205020A priority Critical patent/AU2003205020B2/en
Publication of WO2003088889A1 publication Critical patent/WO2003088889A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A61H23/0254Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with rotary motor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16Physical interface with patient
    • A61H2201/1602Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/1623Back
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16Physical interface with patient
    • A61H2201/1602Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/1628Pelvis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16Physical interface with patient
    • A61H2201/1602Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/164Feet or leg, e.g. pedal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2203/00Additional characteristics concerning the patient
    • A61H2203/04Position of the patient
    • A61H2203/0406Standing on the feet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2203/00Additional characteristics concerning the patient
    • A61H2203/04Position of the patient
    • A61H2203/0443Position of the patient substantially horizontal
    • A61H2203/0456Supine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2203/00Additional characteristics concerning the patient
    • A61H2203/04Position of the patient
    • A61H2203/0443Position of the patient substantially horizontal
    • A61H2203/0468Prone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/08Trunk
    • A61H2205/081Back
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/08Trunk
    • A61H2205/083Abdomen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/10Leg

Definitions

  • SELF ADMINISTERED LYMPHATIC MASSAGE FIELD OF THE INVENTION relates to self administered lymphatic massage and in particular but not limited to self administered treatment for chronic primary or secondary leg lymphoedema and to a therapeutic pad suitable for that and other similar treatments.
  • BACKGROUND TO THE INVENTION Home based use of management aids for chronic non life threatening disorders such as lymphoedema can be an acceptable mainstay for those persons who are unable to attend clinics or practitioners or who live in rural or remote areas.
  • Home management can supplement other forms of more intensive treatment from practitioners in a cost-effective manner which also provides control and empowerment to the affected individual.
  • Some 30% of men and women who undergo unilateral or bilateral groin and/or abdominal clearance develop unilateral or bilateral lymphoedema at a time after the surgery and/or radiotherapy whilst another 30% suffer some forms of subjective inconvenience such as pains, heaviness, tension, problems with range of movement, an inability to undertake activities of daily living and associated problems with quality of life. Therefore early and continuing control and management of this condition is of prime importance.
  • the present invention resides in a self administered therapeutic lymphatic drainage massage pad employing a vibratory source, preferably in the form of a motor having a rotating shaft adapted to rotate eccentrically, the shaft being journalled in flexible bearings so that eccentricity causes rotary vibration, a vibratory cushion assembly driven by the vibratory source, the cushion assembly having an applicator surface and communicating the vibration from the vibratory source along the cushion assembly and delivering vibration therapy to a user through the applicator surface, the amplitude and frequency being selected to effect lymphatic drainage therapy over the applicator surface in contact with the user.
  • a vibratory source preferably in the form of a motor having a rotating shaft adapted to rotate eccentrically, the shaft being journalled in flexible bearings so that eccentricity causes rotary vibration
  • a vibratory cushion assembly driven by the vibratory source
  • the cushion assembly having an applicator surface and communicating the vibration from the vibratory source along the cushion assembly and delivering vibration therapy to a user through the applicator surface, the amplitude and frequency being selected to effect lymphatic drainage therapy over
  • the vibration is typically imparted to a housing in which a motor is housed.
  • the motor housing is typically connected to one end of the cushion assembly, the cushion assembly comprising a frame covered by cushion material the frame being connected to the housing for operative conduction of the rotary vibration to the applicator surface.
  • the rotary vibration is transmitted from the housing to the frame in the cushion and then to the user who places a body part on the cushion to receive the conducted vibrations.
  • the pad is preferably of the type described in US Patent No. 3,019,785 to Eiden entitled Vibratory Massage Cushion and modified to provide to mimic lymphatic drainage therapy according to the following description.
  • Thedisclosure of US Patent No. 3,019,785 is incorporated herein by reference. Reference should be made to this patent which exemplifies the type of construction that may be employed to enable transmission of a rotary vibration to an application surface.
  • This type of massager may be purchased from Niagara Therapy Manufacturing Limited, pertinent address being as follows Niagara Therapy Manufacturing (Aust.) Pty Ltd, 16/18 Josephine Street, Loganholme, Brisbane, Queensland, Australia; Niagara of America Inc., 703 Westover Street, Gastonia, N. C. 28056, United States of America; and Niagara Manufacturing Ltd., Colmendy Industrial Estate, Ryl Road, Denbigh, Clwyd, LT 165TS, United Kingdom and known as the "Niagara Thermo Cyclopad”.
  • This pad is for general use and is not designed for any specific therapeutic application.
  • the pad operates at higher frequencies than proposed in the present invention and is specifically marketed for its proprietary "Cycloid Polymodulation" where the frequency is automatically modulated.
  • the present invention optimises clinical effectiveness by applying a hitherto unexpected application of this type of device at a low frequency. It will therefore be appreciated that although the same type of construction may be employed the pad of the present invention is a different pad.
  • a massage pad operating at low frequency to mimic lymphatic drainage massage and having a rotary vibratory source and a vibratory transmitter located within the pad and communicating with the rotary vibratory source
  • the treatment method comprising the steps of:- application of the pad to the lower back, with the body position lying face up, subsequently application of the pad on the abdomen with the body position lying face down, subsequently application of the pads on the top of thighs body position lying down, subsequently application of the pad underthighs, body position lying face up, and subsequently application of the pad under calves, body position lying face up.
  • the total application time may vary as may the order of application to any part, typically the total time is 1 hour evenly applied to each part.
  • the vibratory source is set to a frequency of not more than 50
  • a massage pad assembly having a rotary vibratory source and a vibratory transmitter located within the pad and communicating with the rotary vibratory source, the assembly being configured to mimic manual lymphatic drainage massage when applied to a patient.
  • the pad is driven by a motor having a central shaft and an eccentric mass located mass on a projecting portion of the shaft.
  • the attached drawing Figure 1 illustrates a pad assembly comprising a drive motor housing 11 connected to a vibratory frame 12 located inside a cushion assembly 13 shown in phantom.
  • the cushion assembly is substantially as described in US patent 3,019,785.
  • a d.c. motor 14 drives a shaft 15 which carries a weight 16 so the shaft is unbalanced.
  • the shaft travels in self-centring bearings and is driven in this embodiment at a fixed therapeutic frequency of 47Hz to mimic manual lymphatic drainage massage.
  • the frequency may be a specialised selectable addition to the available frequency and operational modes available on current commercial units such as the Niagara Cyclopad.
  • the rotary vibration as applied to a patient at the delivery is termed "cycloid vibration therapy".
  • Leg Volumes Leg volume (mis) showed good clinical change after three weeks of massage pad use. Affected leg size continued to decrease when measured at the four-week post treatment follow up, as demonstrated in the table below.
  • Trunk fluids ICF+ECF
  • Fibrotic induration Softness in the calves increased throughout three weeks of using the massage pad. Minimal changes were recorded at the anterior or posterior thigh. Below is a table showing changes to resistance to compression (in arbitrary units)-for the calf
  • Symptoms Participants reported statistically significantly fewer symptoms for 8 of the 10 symptoms measured throughout the trial. Significant changes were reported after both the first week and the third week of massage pad use for tightness, heaviness, cramps pins and needles, skin dryness and size difference (perceived amount of swelling). Reported pain significantly decreased after the first week of massage pad use, however this was not maintained in the following weeks. Reported mobility significantly increased after three weeks of massage pad use. Symptoms which did not change significantly after use of the massage pad were burning feeling and perceived temperature difference. Some 40% of the participants reported improvements in the fit of their clothing and shoes. Other significant comments included symptomatic improvement and a feeling of relaxation Side effects: Reported side effects were slight nausea, light-headedness, headaches and increased joint pain (in-patients with pre-existing joint conditions)). None of which were particularly strong or clinically significant.
  • leg volumes for this group increased in the short term (after one and two weeks of therapy) before decreasing.
  • Cycloid vibration therapy had a significant short-term effect on the amount of total leg fluids.
  • Good clinical effects were also obtained after three weeks and at follow up, indicating a possible trend. Trunk fluid and extra cellular fluid also reduced by clinically significant amounts after cycloid vibration therapy, however these reductions were not maintained at the follow up. This fact suggests that ongoing use of the equipment is likely to produce a beneficial ongoing positive effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Percussion Or Vibration Massage (AREA)

Abstract

A pad assembly comprising a drive motor housing 11 connected to a vibratory frame 12 located inside a cushion assembly 13 shown in phantom. A d.c. motor 14 drives a shaft 15 which carries a weight 16 so the shaft is unbalanced. The shaft travels in self-centring bearings and is driven at a fixed therapeutic frequency of 47Hz to mimic manual lymphatic drainage massage.

Description

SELF ADMINISTERED LYMPHATIC MASSAGE FIELD OF THE INVENTION THIS invention relates to self administered lymphatic massage and in particular but not limited to self administered treatment for chronic primary or secondary leg lymphoedema and to a therapeutic pad suitable for that and other similar treatments.
BACKGROUND TO THE INVENTION Home based use of management aids for chronic non life threatening disorders such as lymphoedema can be an acceptable mainstay for those persons who are unable to attend clinics or practitioners or who live in rural or remote areas. Home management can supplement other forms of more intensive treatment from practitioners in a cost-effective manner which also provides control and empowerment to the affected individual. Some 30% of men and women who undergo unilateral or bilateral groin and/or abdominal clearance develop unilateral or bilateral lymphoedema at a time after the surgery and/or radiotherapy whilst another 30% suffer some forms of subjective inconvenience such as pains, heaviness, tension, problems with range of movement, an inability to undertake activities of daily living and associated problems with quality of life. Therefore early and continuing control and management of this condition is of prime importance. Previous reports have suggested that multidirectional vibration therapy may improve tissue health through facilitating a reduction in tissue congestion (oedema) and improved wound healing but to date there has not been any systematic approach for self administration. The alternative is to employ a massage therapist and of course the costs are much higher than an effective self administered regime.
It is an object of the present invention to provide an effective self administered regime.
OUTLINE OF THE INVENTION
In one aspect the present invention resides in a self administered therapeutic lymphatic drainage massage pad employing a vibratory source, preferably in the form of a motor having a rotating shaft adapted to rotate eccentrically, the shaft being journalled in flexible bearings so that eccentricity causes rotary vibration, a vibratory cushion assembly driven by the vibratory source, the cushion assembly having an applicator surface and communicating the vibration from the vibratory source along the cushion assembly and delivering vibration therapy to a user through the applicator surface, the amplitude and frequency being selected to effect lymphatic drainage therapy over the applicator surface in contact with the user.
The vibration is typically imparted to a housing in which a motor is housed. The motor housing is typically connected to one end of the cushion assembly, the cushion assembly comprising a frame covered by cushion material the frame being connected to the housing for operative conduction of the rotary vibration to the applicator surface. The rotary vibration is transmitted from the housing to the frame in the cushion and then to the user who places a body part on the cushion to receive the conducted vibrations.
The pad is preferably of the type described in US Patent No. 3,019,785 to Eiden entitled Vibratory Massage Cushion and modified to provide to mimic lymphatic drainage therapy according to the following description. Thedisclosure of US Patent No. 3,019,785 is incorporated herein by reference. Reference should be made to this patent which exemplifies the type of construction that may be employed to enable transmission of a rotary vibration to an application surface. This type of massager may be purchased from Niagara Therapy Manufacturing Limited, pertinent address being as follows Niagara Therapy Manufacturing (Aust.) Pty Ltd, 16/18 Josephine Street, Loganholme, Brisbane, Queensland, Australia; Niagara of America Inc., 703 Westover Street, Gastonia, N. C. 28056, United States of America; and Niagara Manufacturing Ltd., Colmendy Industrial Estate, Ryl Road, Denbigh, Clwyd, LT 165TS, United Kingdom and known as the "Niagara Thermo Cyclopad".
This pad is for general use and is not designed for any specific therapeutic application. In particular the pad operates at higher frequencies than proposed in the present invention and is specifically marketed for its proprietary "Cycloid Polymodulation" where the frequency is automatically modulated.
The present invention optimises clinical effectiveness by applying a hitherto unexpected application of this type of device at a low frequency. It will therefore be appreciated that although the same type of construction may be employed the pad of the present invention is a different pad.
In another aspect there is provided method of self administered massage employing a massage pad operating at low frequency to mimic lymphatic drainage massage and having a rotary vibratory source and a vibratory transmitter located within the pad and communicating with the rotary vibratory source, the treatment method comprising the steps of:- application of the pad to the lower back, with the body position lying face up, subsequently application of the pad on the abdomen with the body position lying face down, subsequently application of the pads on the top of thighs body position lying down, subsequently application of the pad underthighs, body position lying face up, and subsequently application of the pad under calves, body position lying face up.
The total application time may vary as may the order of application to any part, typically the total time is 1 hour evenly applied to each part. Preferably, the vibratory source is set to a frequency of not more than 50
Hertz and at a frequency and amplitude conceived to mimic manual lymphatic drainage massage. The objective being to clear lymph nodes and vessels in the abdomen and lower back before working downward and clearing vessels in the thigh and calves. Accordingly, in another aspect there is provided a massage pad assembly having a rotary vibratory source and a vibratory transmitter located within the pad and communicating with the rotary vibratory source, the assembly being configured to mimic manual lymphatic drainage massage when applied to a patient. Preferably the pad is driven by a motor having a central shaft and an eccentric mass located mass on a projecting portion of the shaft.
The applicant has carried out clinical trials in relation to this process with a frequency setting of 47 hertz in the prototype unit but is of the view that lower frequencies may be more effective than the results depicted in the clinical trials set out below. It is to be noted that in addition to the present methods not having been used before an unexpected result of the treatment was a reduction in body mass in relation to the treatment of chronic primary and secondary leg lymphoedema.
BRIEF DESCRIPTION OF THE DRAWINGS In order that the present invention maybe more readily understood and be put into practical effect reference will be made to the accompanying schematic drawing of a pad and the following report arising from clinical trials. METHOD OF PERFORMANCE
The attached drawing Figure 1 illustrates a pad assembly comprising a drive motor housing 11 connected to a vibratory frame 12 located inside a cushion assembly 13 shown in phantom. The cushion assembly is substantially as described in US patent 3,019,785. A d.c. motor 14 drives a shaft 15 which carries a weight 16 so the shaft is unbalanced. The shaft travels in self-centring bearings and is driven in this embodiment at a fixed therapeutic frequency of 47Hz to mimic manual lymphatic drainage massage. The frequency may be a specialised selectable addition to the available frequency and operational modes available on current commercial units such as the Niagara Cyclopad. The rotary vibration as applied to a patient at the delivery is termed "cycloid vibration therapy".
Reference will now be made to clinical trials. Methods All participants used the massage pad as outlined below for a total time of one hour distributed evenly across the 5 areas. This regimen was designed to simulate the sequence used during a lymphoedema drainage massage such as manual lymphatic drainage (although it is acknowledged that the exact nature cannot be mimicked). The aim being to clear lymph nodes and vessels in the abdomen and low back before working downward and clearing vessels in the thighs and calves.
Figure imgf000006_0001
* participants position when using the pad Measurement All patients were measured prior to entry into the study, at 1 , 2, and 3 week and then one month after cessation of the use of the massage pad. Limb Circumference and Volumes
Patients total leg limb volume and circumference was measured using a Perometer® which measures limb circumference at 4mm intervals and calculates limb volume. This equipment's accuracy and reproducability has been validated by independent researchers. (Stanton et al 1997, 2000, Tierney et al 1996).
Extracellular and Intracellular fluids, Fat and other composition parameters Bio-impedance is being increasingly used as an early indicator of change in oedematous/lymphoedematous limbs with recent studies confirming the validity and accuracy of the process. (Thomas et al 1992, Cornish 2000, Cornish et al 1996, 2001, Filler and Cornish, 2000) Patients' Body composition (including intra cellular and extra cellular fluid and segmental fluid distribution in the legs and trunk) was measured using the In Body bioimpedance system. (Cha et al 1997). This system works by passing a number of different frequencies of electrical current (5 - 500Hz) through the body from one electrode to one of the other 7 electrodes and while this occurs the resistance to flow is determined. Since different frequencies take different paths by mathematical modelling it is possible to determine a range of body parameters such as fluids, fat and muscle masses. Fibrotic Induration:
As an oedema or lymphoedema progresses the fluid may change to fibrous tissues as a consequence of the sub clinical inflammatory processes which occur. Any fibre build up can significantly impinge on lymphatic drainage, so it is very important to detect this fibrous tissue and to see if treatment has an effect on it. Build up of fibrous tissue was measured using a tonometer, which uses defined weight to measure the resistance of tissues, with greater resistance indicating fibrotic induration. (Casley-Smith, etal 1993, Liu and Olszewski, 1992, Clodius et al, 1976) Fibrotic induration was measured at three sites on each limb, these being the calf and upper anterior and posterior thigh. 1 Subjective Measures:
Prior to and at each assessment participants were asked to rate their experience of 20 aspects of quality of life and activities of daily living, using a 10 point Likert rating scale. Their experience of pain was measured using the short form McGill Pain Questionnaire (MPQ). They also rated 10 symptoms commonly associated with chronic swelling such as tightness, heaviness, cramps, skin dryness burning feelings etc using a 10 point Likert scale. (1 = no problem or issue to 10 = worst imaginable problem or issue). Perception of performance of, and satisfaction with, valued occupations was measured using the Canadian Occupational Performance Measure (COPM). Participants were also asked if they experienced any side effects while using the massage pad. The very significant results from these aspects of the study are to be reported at the World Occupational Therapy Congress in Stockholm in 2002. Analysis
Data was analysed using SPSS. Median analysis was performed where data was not normally distributed. Results:
Leg Volumes Leg volume (mis) showed good clinical change after three weeks of massage pad use. Affected leg size continued to decrease when measured at the four-week post treatment follow up, as demonstrated in the table below.
Figure imgf000007_0001
Affected leg volume - clinical changes
Figure imgf000008_0001
Leg fluids. Statistically significant results were obtained for affected leg fluid after the first week of massage pad use (p=.032). Results for weeks 1 and 3 for affected leg fluid were clinically significant, while at the four week follow up 55.5% of this group (n=27) had less fluid than at the third week measurement, with 3 participants (11.1%) having a decrease of > 480ml. Below is a table of affected leg fluid (ICF+ECF), showing changes in litres
Figure imgf000008_0002
Affected leg fluid - Clinical changes
Figure imgf000008_0003
Truncal fluids. Total trunk fluid decreased over three weeks of massage pad use after initially increasing. Results for the second and third weeks of massage pad use were clinically significant. At the four week follow up measurement trunk fluid had increased again - indicating that the massage pad had had a significant effect on truncal fluids. Below is a table showing changes in Trunk fluids (ICF+ECF), litres.
Figure imgf000009_0001
Trunk fluid - clinical changes
Figure imgf000009_0002
Total body Extracellular fluid. These values also showed some clinical change after two and three weeks of massage pad use, however these changes were not maintained at the 1 month follow up. Below is a table of the changes in the total extracellular fluid (litres)
Figure imgf000009_0003
Median total fluids - whole body - clinical changes
Figure imgf000009_0004
Fibrotic induration. Softness in the calves increased throughout three weeks of using the massage pad. Minimal changes were recorded at the anterior or posterior thigh. Below is a table showing changes to resistance to compression (in arbitrary units)-for the calf
Figure imgf000010_0001
Body composition. The lymphoedema group experienced a decrease in body fat mass of 2.2kg (6.7%, p=0.859) after three weeks of massage pad use. At the follow up measurement they had still a decrease of 1.0kg (3% of initial reading, p=0.531). After three weeks massage pad use this group had a decrease in percentage body fat of 0.55% (p=0.772) which had returned to the same as initial reading at the follow up measurement. Body mass index decreased by 0.3 kg/m2 (1%, p=0.978) after three weeks of massage pad use and had returned to the same as initial reading at the follow up measurement. Basal metabolic rate increased by 40.45 Kcal (3.1%, p=0.783) after three weeks massage pad use. It was still increased by 29.4 Kcal (2.25%, p=0.969) at the follow up measurement. Subjective results:
Symptoms: Participants reported statistically significantly fewer symptoms for 8 of the 10 symptoms measured throughout the trial. Significant changes were reported after both the first week and the third week of massage pad use for tightness, heaviness, cramps pins and needles, skin dryness and size difference (perceived amount of swelling). Reported pain significantly decreased after the first week of massage pad use, however this was not maintained in the following weeks. Reported mobility significantly increased after three weeks of massage pad use. Symptoms which did not change significantly after use of the massage pad were burning feeling and perceived temperature difference. Some 40% of the participants reported improvements in the fit of their clothing and shoes. Other significant comments included symptomatic improvement and a feeling of relaxation Side effects: Reported side effects were slight nausea, light-headedness, headaches and increased joint pain (in-patients with pre-existing joint conditions)). None of which were particularly strong or clinically significant.
Participants with lymphoedema experienced a good clinical decrease in leg volume after three weeks of cycloid vibration therapy and also when measured at the 1 month follow up. This maintenance of leg volume reduction may indicate a longer-term effect of the therapy. It is not clear however why leg volumes for this group increased in the short term (after one and two weeks of therapy) before decreasing. Cycloid vibration therapy had a significant short-term effect on the amount of total leg fluids. Good clinical effects were also obtained after three weeks and at follow up, indicating a possible trend. Trunk fluid and extra cellular fluid also reduced by clinically significant amounts after cycloid vibration therapy, however these reductions were not maintained at the follow up. This fact suggests that ongoing use of the equipment is likely to produce a beneficial ongoing positive effect. Resistance to compression (fibrotic induration) at the calf was reduced after three weeks of vibration therapy, however this change was not maintained when measured at the follow up. This suggests that ongoing ifse of the equipment is likely to produce a beneficial ongoing positive effect. Body fat mass decreased by 2.2 kg after therapy and this group still had a 1 kg loss in body fat mass when measured at the follow up, which are clinically significant findings. Changes to body mass index, body fat mass weight and leg volume were associated in this group, indicating that the therapy may have had a systemic effect on these participants. These reductions are very relevant and exciting since body mass is one of the major exacerbating factors of lymphoedema and a reduction is likely to have significant benefit on the patient 's lymphatic system. It may also be beneficial for those with decreased mobility who can not undertake more strenuous exercise. The very significant subjective improvements in performance of valued daily activities improved (p=.000, n=33) and in patients satisfaction with performance of daily activities and in activities of daily living (to be reported elsewhere) show great benefits even after three weeks of Niagara massage pad use. References Bates, DO, Levick, JR and Mortimer, PS 1994. Quantification of rate and depth of pitting in human oedema using an electronic tonometer. Lymphology 27 159-
172
Casley-Smith, JR, Morgan, RW and Piller, NB 1993 Treatment of lymphoedema of the arms and legs New England Journal of Medicine, 329 1158-1163
Cha, K Shin, S, Shon, C Choi, S and Wilmore, S 1997, Evaluation of segmental bio electrical impedance analysis for measuring muscle distribution J ICHPER,
11-14
Clodius L, Deak & Piller N 1976 A new instrument for the evaluation of tissue tonometry in lymphoedema. Lymphology 9: 1-5
Cornish B, Bunce I & Ward L 1996 Bio-electrical impedance for monitoring the efficacy of lymphoedema treatment programs. Breast Cancer Research and
Treatment 38: 169-76
Cornish, BH 2000 Bioelectrical impedance analysis revisited Lymphology 33 136-137
Cornish, BH Chapman, M Hirst, C, Mirolo, B, Bunce, IH Ward LC and Thomas,
BJ 2001 Early diagnosis of lymphoedema using multi-frequency bioimpedance
Lymphology 34 (1),2-11
Leduc, A Lievens, P and Dewald, J 1981, The influence of multidirectional vibrations on wound healing and regeneration of blood and lymph vessels.
Lymphology, 14, 179-185
Liu N, Olszewski W 1992 Use of tonometry to assess lower extremity lymphoedema. Lymphology 25: 155-8
Tierney S, Aslem M & Rennie K 1996 Infrared opto-electronic volumetry, the ideal way to measure limb volume. Europ. J Vase. Endovas Surg 12: 412-17
Piller, NB Goodear, M and Peter, D 1998 Lymphoscintigraphic Evidence supports the evidence of axillo-anastomotic pathways in a patient with chronic secondary leg lymphoedema subsequent to inguinal node clearance and radiotherapy. European J Lymphology 6(24) 97-100 Piller, NB and Clodius, L 1976 The use of a tissue tonometer as a diagnostic aid in extremity lymphoedema Lymphology 9 127-132 Piller, NB and Cornish, B 2000 Bio-impedance and Tonometry - Benefits and limitations as diagnostic tools in lymph and other oedemas. Proc Third Australian Lymphology Association Congress. 49-58
Stanton, AWB, Badger, C, Sitza, J 2000 Non invasive assessment of the lymphoedematous limb Lymphology 33 122-135
Stanton, AWB, Northfield, JW, Holryod, B et al 1997 Validation of an optoelectronic limb volumeter (perometer) Lymphology 30, 77-97 Thomas, BJ, Cornish, BH and Ward, LC 1992 Bioelectrical impedance analysis for measurement of body fluid volumes: A review J Clin Eng. 17 505-510 Whilst the above has been given by way of illustrative example of the present invention many variations and modifications thereto will be apparent to those skilled in the art without departing from the broad ambit and scope of the invention as set out in the appended claims.

Claims

1. A self administered therapeutic lymphatic drainage massage pad employing a rotary vibratory source, a vibratory cushion assembly driven by the vibratory source, the cushion assembly having a applicator surface and communicating the vibration from the vibratory source along the cushion assembly and delivering vibration therapy to a user through the applicator surface, the amplitude and frequency being selected to effect lymphatic drainage therapy over the applicator surface in contact with the user.
2. A self administered therapeutic lymphatic drainage massage pad according to claim 1 wherein the vibration is imparted to a housing in which a motor is housed, the motor housing being connected to one end of the cushion assembly, the cushion assembly comprising a frame covered by cushion material, the frame being connected to the housing for operative conduction of the rotary vibration to the applicator surface.
3. A self administered therapeutic lymphatic drainage massage pad according to claim 1 operating at a frequency of less that 50 Hz.
4. A self administered therapeutic lymphatic drainage massage pad according to claim 2 operating at a frequency of less that 50 Hz.
5. A method of self administered lymphatic massage employing a massage pad operating at low frequency to mimic lymphatic drainage massage and having a rotary vibratory source and a vibratory transmitter located within the pad and communicating with the rotary vibratory.source, the treatment method comprising the steps of: application of pad to the lower back, with the body position lying face up, subsequently application of the pad on the abdomen with the body position lying face down, subsequently application of the pads on the top of thighs body position lying down, subsequently application of the pad under thighs, body position lying face up, and subsequently application of the pad under calves, body position lying face up
6. A method of self administered lymphatic massage wherein the total application time is about 1 hour evenly applied to each part
7. A method of self administered lymphatic massage wherein the vibrator source is set to a frequency of not more than 50 Hertz.
PCT/AU2003/000467 2002-04-18 2003-04-17 Self administered lymphatic massage WO2003088889A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003205020A AU2003205020B2 (en) 2002-04-18 2003-04-17 Self administered lymphatic massage

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS1807A AUPS180702A0 (en) 2002-04-18 2002-04-18 Self administered lymphatic massage
AUPS1807 2002-04-18

Publications (1)

Publication Number Publication Date
WO2003088889A1 true WO2003088889A1 (en) 2003-10-30

Family

ID=3835384

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2003/000467 WO2003088889A1 (en) 2002-04-18 2003-04-17 Self administered lymphatic massage

Country Status (2)

Country Link
AU (1) AUPS180702A0 (en)
WO (1) WO2003088889A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2423932A (en) * 2005-03-09 2006-09-13 Vibrant Medical Ltd Cellulite treatment
GB2514587A (en) * 2013-05-30 2014-12-03 Vibrant Medical Ltd Treatment of peripheral arterial disease and other conditions, and apparatus therefor
GB2528968A (en) * 2014-08-07 2016-02-10 Nhc Technology Ltd Cycloidal vibration motor module construction and frame arrangement

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019785A (en) * 1959-05-18 1962-02-06 Niagara Therapy Mfg Corp Vibratory massage cushion
WO2002065973A1 (en) * 2001-02-19 2002-08-29 Vibrant Medical Limited Leg ulcer, lymphoedema and dvt vibratory treatment device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019785A (en) * 1959-05-18 1962-02-06 Niagara Therapy Mfg Corp Vibratory massage cushion
WO2002065973A1 (en) * 2001-02-19 2002-08-29 Vibrant Medical Limited Leg ulcer, lymphoedema and dvt vibratory treatment device

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2423932A (en) * 2005-03-09 2006-09-13 Vibrant Medical Ltd Cellulite treatment
GB2514587A (en) * 2013-05-30 2014-12-03 Vibrant Medical Ltd Treatment of peripheral arterial disease and other conditions, and apparatus therefor
US10980705B2 (en) 2013-05-30 2021-04-20 Vibrant Medical Limited Device for treatment of peripheral arterial disease and micro-angiopathy in lower limbs
GB2528968A (en) * 2014-08-07 2016-02-10 Nhc Technology Ltd Cycloidal vibration motor module construction and frame arrangement
GB2528968B (en) * 2014-08-07 2020-07-15 Nhc Tech Limited Cycloidal vibration motor module construction and frame arrangement

Also Published As

Publication number Publication date
AUPS180702A0 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
US11491328B2 (en) Prevention and treatment of diastolic flow reversal
Porcari et al. Effects of electrical muscle stimulation on body composition, muscle strength, and physical appearance
JP5020971B2 (en) Equipment for continuous pressure technique therapy
Kesar et al. Effects of stimulation frequency versus pulse duration modulation on muscle fatigue
Chleboun et al. Intermittent pneumatic compression effect on eccentric exercise-induced swelling, stiffness, and strength loss
WO2008145724A1 (en) Microcurrent device and therapy
Peer et al. The acute effects of local vibration therapy on ankle sprain and hamstring strain injuries
Guo et al. Whole body vibration training improves walking performance of stroke patients with knee hyperextension: a randomized controlled pilot study
Nasb et al. Sling suspension therapy utilization in musculoskeletal rehabilitation
RU2647184C2 (en) Microcirculation enhancement device
Sawan et al. Effect of shock wave therapy on ankle plantar flexors spasticity in stroke patients
Park et al. Knee-extension exercise’s lack of immediate effect on maximal voluntary quadriceps torque and activation in individuals with anterior knee pain
Winkelmann et al. Acute effects and perceptions of deep oscillation therapy for improving hamstring flexibility
WO2003088889A1 (en) Self administered lymphatic massage
AU2003205020B2 (en) Self administered lymphatic massage
RU2650210C1 (en) Method for rehabilitation of patients after trauma and lesions of the thoracic and lumbar spine
Zbylut et al. Evaluation of therapeutic management in women with lumbar spine pain complaints
Springer et al. Effects of amplitude and phase-duration modification on electrically induced contraction force and discomfort
Patterson et al. The influence of electrode size and type on surface stimulation of the quadriceps
Vrbová et al. Electrical Stimulation for health, Beauty, Fitness, Sports Training and Rehabilitation: A users guide
Galantino et al. Physical therapy management for the patient with HIV: Lower extremity challenges
WO2024007001A2 (en) Exercise apparatus including stimulation and methods of use
RU2035179C1 (en) Method for instrumental massage of body muscles
Gusi et al. EFFECTS OF NEUROMUSCULAR RESPONSES DURING WHOLE BODY VIBRATION EXERCISE WITH DIFFERENT KNEE ANGLES.
Corley et al. The effect of surface neuromuscular electrical stimulation and compression hosiery applied to the lower limb, on the comfort and blood flow of healthy subjects

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2003205020

Country of ref document: AU

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP